新兴的选平台描述了氨基基诺林与脂层的结构-活性关系
Bethany Crow1, Roland Grafstrom2, Vesa Hongisto2
1Schools of Chemistry and Mechanical Engineering, University of Leeds, Leeds LS2 9JT UK.
Bioelectrochemistry (Amsterdam, Netherlands)
|February 6, 2025
概括
氨基基诺林与脂膜相互作用,其亲和力受分子电荷和结构的影响. 这种生物膜亲和度指数与毒性相关,有助于药物安全性评估.
科学领域:
- 生物化学 生物化学
- 药理学 药理学是指药理学的学科.
- 分析化学 分析化学
背景情况:
- 氨基基诺林 (AQ) 和替代氨基诺林 (s-AQ) 是一种具有潜在生物活性的化合物类别.
- 了解它们与生物膜的相互作用对于预测它们的行为和毒性至关重要.
- 现有的方法可能无法完全捕捉这些化合物与脂质双层的微妙相互作用.
研究的目的:
- 通过电化学方法研究氨基基诺林与支持的脂层的相互作用.
- 开发一种定量衡量生物膜亲和度 (log BAI) 的方法,以计算电荷和结构特征.
- 探索生物膜亲和力和化合物毒性之间的关系.
主要方法:
- 利用带有固定人工膜 (IAM) 的高性能液体染色学 (HPLC) 来监测化合物吸附和分离.
- 采用电化学来记录二氧化酸胆 (DOPC) 单层和IAMs中的相互作用.
- 结合脂友性正常化的结果,得出一个日志生物膜亲和度指数 (日志BAI).
- 使用ChimeraX分子建模来解释结果,并与pKa和ToxScore值相关联的日志BAI.
主要成果:
- 逻辑BAI显示与氨基基诺林pKa值的线性关系,表明相互作用是由分子正电荷和-NH2组的特性驱动的.
- 与线性差异的偏差表明了结的变化和脂层内的位置.
- 替代的氨基基诺林显示了日志BAI和其毒素评分之间的功率相关性,将膜相互作用与毒性联系起来.
结论:
- 开发的HPLC-IAM方法有效量化了氨基基诺林与生物膜的相互作用,反映了电荷和结构贡献.
- 生物膜亲和力,根据LOG BAI测量,是氨基诺林毒性的重要预测指标.
- 这种方法为药物设计和氨基基诺林衍生物的安全性评估提供了宝贵的见解.
更多相关视频
07:11Dissipative Microgravimetry to Study the Binding Dynamics of the Phospholipid Binding Protein Annexin A2 to Solid-supported Lipid Bilayers Using a Quartz Resonator
Published on: November 1, 2018
7.0K
08:31Biosensor-based High Throughput Biopanning and Bioinformatics Analysis Strategy for the Global Validation of Drug-protein Interactions
Published on: December 1, 2020
4.9K
相关概念视频
01:35Asymmetric Lipid Bilayer
7.2K
Biological membranes show uneven distribution of different types of lipids in the inner and outer layers, resulting in transverse asymmetric membranes. The treatment of the erythrocyte membrane with the enzyme phospholipase confirmed the asymmetric nature of the lipid bilayer. The enzyme hydrolyzes lipids into fatty acids and hydrophilic groups. The phospholipase acts only on the outer layer of the membrane, while the inner layer remains intact. The phospholipase treatment resulted in 80%...
7.2K
01:28Structure-Activity Relationships and Drug Design
493
Drug design is a dynamic field that involves discovering and developing new medications based on specific biological targets. This process heavily relies on structure-activity relationships (SAR) and quantitative structure-activity relationships (QSAR) to guide the design and optimization of efficient drugs.
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
SAR studies the intricate relationship between a drug's chemical structure and biological activity. It focuses on understanding how modifications to a drug's structure can influence...
493